- Prostate atypia: clinical and pathological variables associated with cancer diagnosis on repeat biopsy. Kopp, R. P.; Parsons, J. K.; Shiau, J.; Wang-Rodriguez, J.; Palazzi-Churas, K.; Silberstein, J. L.; Derweesh, I. H.; Sakamoto, K. // Prostate Cancer & Prostatic Diseases;2011, Vol. 14 Issue 2, p149
The clinical significance of atypical glands suspicious for malignancy (atypia) on prostate biopsy is unclear. We studied a cohort of 139 patients with atypia who underwent repeat prostate biopsy. We analyzed clinical and pathological variables that may be associated with cancer on repeat...
- Dissect lymph nodes to gauge status, predict outcome. Scheck, Anne // Urology Times;May99, Vol. 27 Issue 5, p12
Reports on the assertions of physician Nelson Stone about the usability of pelvic lymph node dissection prior to seed implantation for prostate cancer in predicting treatment outcome. Criteria for dissecting lymph a node; Importance of accurate cancer staging in the technique; Advantage of the...
- Cutoff point of 25% found to be ideal for free PSA. Nelson, Roscoe // Urology Times;Mar99, Vol. 27 Issue 3, p7
Reports on the results of a prospective, multicenter trial which concluded that measuring free PSA levels with a cutoff point of 25% can reduce the number of unnecessary biopsies while detecting the vast majority of prostate cancers. Guidelines for the use of free PSA.
- The national burden of infections after prostate biopsy in England and Wales: a wake-up call for better preventionâ€”authors' response. Batura, Deepak; Gopal Rao, Guduru // Journal of Antimicrobial Chemotherapy (JAC);Oct2013, Vol. 68 Issue 10, p2419
A reply to the letter to the editor is presented in response to the article "The national burden of infections after prostate biopsy in England and Wales: A wake-up call for better prevention."
- Comment on: The national burden of infections after prostate biopsy in England and Wales: a wake-up call for better prevention. Balakrishnan, Indran; Smith, Gillian // Journal of Antimicrobial Chemotherapy (JAC);Oct2013, Vol. 68 Issue 10, p2418
A letter to the editor is presented in response to the article "The national burden of infections after prostate biopsy in England and Wales: A wake-up call for better prevention."
- Factor percent positive biopsies into PCa nomograms. Newman, Laura // Urology Times;Jul2001, Vol. 29 Issue 7, p15
Reports that percent positive biopsies is an independent predictive variable that should be factored into nomograms for prostate cancer, according to researcher Gary D. Grossfeld. Details of Grossfeld's study of the CaPSURE registry of prostate cancer patients presented during the American...
- Errata. // Journal of Clinical Pathology;Jul2015, Vol. 68 Issue 7, pe2
A correction to the study "Prostate Biopsy Concordance in a Large Population-Based Sample: A Surveillance, Epidemiology and End Results Study," by D. Schreiber, A. T. Wong and J. Rineer, published in the 2015 issue is presented.
- More Biopsy Cores Do Not Up PCa Detection. // Renal & Urology News;May2013, Vol. 12 Issue 5, p14
The article presents the study on the increased number of prostate biopsy cores from 12 to 20 offers no advantage in the detection of prostate cancer (PCa).
- Devising and external validation of a prognostic classification of metastatic involvement risk to pelvic lymph nodes in patients with newly diagnosed prostate cancer. Leusik, E. A.; Demeshko, P. D.; Krasny, S. A. // Oncourology;2015, Vol. 11 Issue 4, p59
Objective: assessing the predictive significance of clinical, histologic and biochemical factors for prediction of metastases in pelvic lymph nodes (MPLN), devising and validating of prognostic classification. Material and methods: the study enrolled 1140 patients subjected to radical...